Horan Securities’s Boston Scientific BSX Stock Holding History

Horan Securities’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-50	Closed	-$2.31K	–	755
2022 Q4	$2.31K	Buy	+50	New	+$2.17K	﹤0.01%	546

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Horan Securities's BSX Position: Q1 2023 in Review

Horan Securities sold out of Boston Scientific (BSX) in Q1 2023, closing a stake of 50 shares — an estimated $2.31K sold.

Horan Securities first reported a position in BSX in Q4 2022 and held it in 1 quarter. The position peaked at $2.31K in Q4 2022. 996 funds tracked by Wall St. Rank hold BSX as of Q1 2023.

Horan Securities reported no remaining Boston Scientific position as of Q1 2023 after selling out during the quarter.
Horan Securities sold 50 Boston Scientific shares in Q1 2023, an estimated $2.31K.
Horan Securities first reported a position in Boston Scientific in Q4 2022 and held it in 1 quarter.
Horan Securities's Boston Scientific position peaked at $2.31K in Q4 2022.
996 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2023.

Based on Horan Securities's 13F filing for Q1 2023, filed 18 Apr 2023.